Company CVAbout Jeevan Scientific Technology Ltd 
Jeevan Scientific Technology Ltd
Micro Cap
Pharmaceuticals & Drugs
Jeevan Scientific Technology Ltd (Erstwhile Jeevan Softech Limited) was incorporated on 2nd February, 1999 to carry on the business Clinical research, Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable, cost effective and technology-driven clinical research solutions to various clients across the globe.
Company Coordinates
Company Details
Plot 1 & 2 Sai Krupa Enclave, Manikonda Jagir Nr Lanco Hills Hyderabad Telangana : 500008
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 15.48 Cr
Number of Shares
1.55 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Feb-2023
1.55
15.48
178750
10
Issued under ESOP Scheme
12-Jun-2018
1.53
15.30
3842000
10
Conversion of Warrants
06-Mar-2018
1.15
11.46
2180000
10
Conversion of Warrants
30-Mar-2017
92.79
9.28
1165000
10
Conversion of Warrants
13-Dec-2016
81.14
8.11
2072865
10
Allotment of Equity To Others
13-Dec-2016
81.14
8.11
2072865
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Krishna Kishore Kuchipudi (12.22%)
Highest Public shareholder
Dheeraj Kumar Lohia (3.35%)
Individual Investors Holdings
45.91%
Board of Directors
Management
Designation
Remuneration
K Krishna Kishore
Vice Chairman & M.D.
54.0 lacs
T Ravi Babu
Director
65.0 k
G Bhanu Prakash
Independent Director
1.1 lacs
Koteswara Rao SSR
Chairman & Independent Directo
95.0 k
K Rama Krishna Prasad
Director
60.0 k
Snigdha Mothukuri
Executive Director & CEO
10.0 lacs
K. Jeevan Krishna
Director
25.0 k
Sharvari Swapnil Shinde
Company Secretary
0
Nageswar Rao Yarllagadda
Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Clinical Research Services
17.27
89.66%
Data Management Service Charges
1.99
10.34%
Clinical Research Services
Clinical Research Services
Data Management Service Charges
Data Management Service Charges
Stock DNARevenue and Profits:
Net Sales:
13 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 66 Cr (Micro Cap)
66.00
33
0.00%
0.27
0.24%
1.32
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
